Seres Therapeutics (MCRB) Reports Q2 2026 Results

What Happened
Seres Therapeutics, Inc. announced its financial results and operational updates for the quarter ended June 30, 2026 on August 5, 2026. The company furnished the press release describing those quarterly results as Exhibit 99.1 to the Form 8‑K filed the same day.

Key Details

• Announcement date: August 5, 2026 (Form 8‑K filed under Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Quarter ended June 30, 2026 (Q2 2026).
• Press release: Furnished as Exhibit 99.1 to the Current Report on Form 8‑K.
• Interactive XBRL cover page included as Exhibit 104.

Why It Matters
This 8‑K provides investors with Seres’ latest quarterly results and operational updates (earnings, revenue and other performance measures are detailed in the press release exhibit). Retail investors should review the Exhibit 99.1 press release for the specific financial figures and any guidance or business updates, and watch for the company’s subsequent SEC filings (such as the Form 10‑Q) for full financial statements and additional disclosure.